Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Turning a blind eye: why we don't test for blindness at the end of our trials.

Literature DB >> 15130997

Turning a blind eye: why we don't test for blindness at the end of our trials.

David L Sackett.

Abstract

Entities: Disease

Mesh：

Year: 2004 PMID： 15130997 PMCID： PMC406365 DOI： 10.1136/bmj.328.7448.1136-a

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

2 in total

Review 1. Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials.

Authors: Dean Fergusson; Kathleen Cranley Glass; Duff Waring; Stan Shapiro
Journal: BMJ Date: 2004-01-22

2. A randomized trial of aspirin and sulfinpyrazone in threatened stroke.

Authors:
Journal: N Engl J Med Date: 1978-07-13 Impact factor: 91.245

2 in total

13 in total

1. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.

Authors: David Moher; Sally Hopewell; Kenneth F Schulz; Victor Montori; Peter C Gøtzsche; P J Devereaux; Diana Elbourne; Matthias Egger; Douglas G Altman
Journal: BMJ Date: 2010-03-23

Review 2. Assessing blinding in randomised controlled trials of acupuncture: challenges and recommendations.

Authors: Ann K Hopton; Hugh Macpherson
Journal: Chin J Integr Med Date: 2011-02-27 Impact factor: 1.978

3. Inadequate description of placebo and sham controls in a systematic review of recent trials.

Authors: Rebecca K Webster; Jeremy Howick; Tammy Hoffmann; Helen Macdonald; Gary S Collins; Jonathan L Rees; Vitaly Napadow; Claire Madigan; Amy Price; Sarah E Lamb; Felicity L Bishop; Klara Bokelmann; Andrew Papanikitas; Nia Roberts; Andrea W M Evers
Journal: Eur J Clin Invest Date: 2019-09-30 Impact factor: 4.686

Turning a blind eye: why we don't test for blindness at the end of our trials.

Review 1. Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials.

2. A randomized trial of aspirin and sulfinpyrazone in threatened stroke.

1. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.

Review 2. Assessing blinding in randomised controlled trials of acupuncture: challenges and recommendations.

3. Inadequate description of placebo and sham controls in a systematic review of recent trials.

4. Use of dose modification schedules is effective for blinding trials of warfarin: evidence from the WASID study.

5. Cellulite and extracorporeal Shockwave therapy (CelluShock-2009)--a randomized trial.

Review 6. Acupuncture for peripheral joint osteoarthritis.

Review 7. Towards a proposal for assessment of blinding success in clinical trials: up-to-date review.

Review 8. Reporting methods of blinding in randomized trials assessing nonpharmacological treatments.

9. Error augmentation enhancing arm recovery in individuals with chronic stroke: a randomized crossover design.

Review 10. Maintenance of Blinding in Clinical Trials and the Implications for Studying Analgesia Using Cannabinoids.